Average Co-Inventor Count = 4.80
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Praxis Precision Medicines, Inc. (19 from 28 patents)
2. Icagen, Inc. (13 from 101 patents)
3. Pfizer Corporation (9 from 4,455 patents)
4. Glaxo Wellcome Inc. (2 from 281 patents)
35 patents:
1. 12479844 - Ion channel modulators
2. 12344615 - Substituted pyridines as ion channel modulators
3. 12325711 - 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulator
4. 12145939 - Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
5. 12030881 - Ion channel modulators
6. 11918571 - Compounds and their methods of use
7. 11866439 - Ion channel modulators
8. 11773099 - Compounds and their methods of use
9. 11767325 - Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
10. 11731976 - 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator
11. 11731978 - 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator
12. 11731966 - Compounds and their methods of use
13. 11629146 - Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity
14. 11505554 - Substituted pyridines as ion channel modulators
15. 11492345 - Compounds and their methods of use